Alex Braun
Head of Investor Relations
Replay available
Acumen Pharmaceuticals, Inc. (ABOS) Q3 2025 Earnings Call
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dan O'Connell
Chief Executive Officer
Matt Zuga
Chief Financial Officer and Chief Business Officer
Dr. Jim Doherty
Chief Development Officer
Dr. Eric Siemers
Chief Medical Officer
Jason Zemanski
Analyst, Bank of America
Tom Schrader
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acumen Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.599 Good day, and welcome to the Acumen Farmer third quarter 2025 conference call and webcast. 00:00:05.599 -- 00:00:08.684 At this time, all participants are in a listen-only mode. 00:00:08.684 -- 00:00:12.369 After the speaker's presentation, there will be a question and answer session. 00:00:12.369 -- 00:00:16.916 To ask a question, please press star 1-1. If your question hasn't been answered and you'd 00:00:16.916 -- 00:00:19.580 like to remove yourself from the queue, press star 1-1 again. 00:00:19.580 -- 00:00:24.628 As a reminder, this call may be recorded. I would now like to turn the call over to Alex 00:00:24.628 -- 00:00:27.993 Braun, head of investor relations. Please go ahead. 00:00:27.993 -- 00:00:32.158 Thanks, Michelle. Good morning, and welcome to the Acumen conference call to discuss 00:00:32.158 -- 00:00:38.542 our business update and financial results for the quarter ended September 30th, 2025. 00:00:38.724 -- 00:00:43.448 With me today are Dan O'Connell, our Chief Executive Officer, and Matt Zuga, our CFO 00:00:43.448 -- 00:00:48.452 and Chief Business Officer. Matt and Dan have some brief prepared remarks, and then 00:00:48.452 -- 00:00:50.995 we'll open the call for questions. 00:00:50.995 -- 00:00:53.277 Joining for the Q&A session, we also have Dr. 00:00:53.277 -- 00:00:56.179 Jim Doherty, our Chief Development Officer, and Dr. 00:00:56.179 -- 00:00:59.532 Eric Siemers, our Chief Medical Officer. 00:00:59.532 -- 00:01:03.278 Before we begin, we encourage listeners to go to the Investors section of the Acumen 00:01:03.278 -- 00:01:07.844 website to find our press release issue this morning that we'll discuss today. 00:01:07.844 -- 00:01:11.249 Please note that during today's conference call, we may make forward-...